Company

Intel Labs

Deep tech company developing reversible cryopreservation technology for human organs to extend transplant logistics windows, with long-term goals of enabling human hibernation.

Healthcare & Biotech

People

Laura Demingceo

Funding History

Sep 22, 2025

Intel Labs (cryopreservation startup) raised $58M total, including $52M in the current round, with Lux Capital and Field Ventures joining. The company is focused on reversible cryopreservation of human organs for transplant patients.

58M

Investors

Lux Capital

News

Interviews (1)

Laura Deming announces $58M raise for cryopreservation startup Intel Labs, targeting organ transplants first

22 Sept 2025